Phase III Study Shows Genentech's Polivy Plus R-CHP Is the First Regimen in 20 Years to Significa...
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the pivotal Phase III POLARIX trial investigating Polivy® (p